Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
Clinical trial NCT02672917 · TERMINATED
Trial details
- NCT number
- NCT02672917
- Sponsor
- BioNTech Research & Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2024-08-07
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.